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A B S T R A C T
Loss of brain glutathione has been associated with cognitive decline and neuronal death during aging and
neurodegenerative diseases. However, whether decreased glutathione precedes or follows neuronal dysfunction
has not been unambiguously elucidated. Previous attempts to address this issue were approached by fully
eliminating glutathione, a strategy causing abrupt lethality or premature neuronal death that led to multiple
interpretations. To overcome this drawback, here we aimed to moderately decrease glutathione content by
genetically knocking down the rate-limiting enzyme of glutathione biosynthesis in mouse neurons in vivo.
Biochemical and morphological analyses of the brain revealed a modest glutathione decrease and redox stress
throughout the hippocampus, although neuronal dendrite disruption and glial activation was conﬁned to the
hippocampal CA1 layer. Furthermore, the behavioral characterization exhibited signs consistent with cognitive
impairment. These results indicate that the hippocampal neurons require a large pool of glutathione to sustain
dendrite integrity and cognitive function.
1. Introduction
When compared with astrocytes, neurons are highly dependent on
oxidative phosphorylation for correct function [2,3], a situation linked
with persistent production of reactive oxygen species (ROS) by the
mitochondrial respiratory chain [4]. Being post-mitotic cells, neurons
are exposed to ROS during longer time periods than dividing cells,
which may contribute to aging and, if inappropriately controlled, to
neurological diseases [5–9]. To modulate the possible deleterious ac-
tions of excess ROS, cells contain glutathione (γ-glutamyl-cysteinyl-
glycine, GSH), an active and ubiquitous antioxidant cofactor re-
sponsible for ROS detoxiﬁcation in neurons [10]. Accordingly, oxida-
tive damage likely caused by progressive GSH deﬁciency is considered
to be one of the earliest biochemical indicator of neuronal degeneration
in aging, Parkinson's disease, and certain mental disorders [11–13]. In
consistency with this notion, over-expression of glutamate-cysteine li-
gase (GCL), i.e. the ﬁrst and rate-limiting step in GSH biosynthesis, in
brain mitochondria protects neurons against neurological deﬁcit in vivo
[10].
Unfortunately, all clinical trials on antioxidants performed so far
have not alleviated the neurological declines in a wide range of dis-
orders [14], which might challenge the oxidative theory of aging and
cognitive impairment [15–17]. Moreover, the lack of an experimental
model that faithfully recreate, in neurons in vivo, the mild mode of
oxidative damage occurring during neurological deterioration, has
hampered understanding the actual role played by ROS in aging and
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neurological disorders. To address this issue, here we designed and
generated a mouse model genetically engineered to knockdown GCL in
neurons of the postnatal mouse brain in vivo. We found that GCL
knockdown caused a moderate decrease in GSH in the neurons of the
CA1 area of the hippocampus that led to dendrite disruption and cog-
nitive impairment. These results reveal that mild oxidative damage in a
discrete group of hippocampal neurons is suﬃcient to trigger the cel-
lular and behavioral signs of neurological disorders.
2. Methods and materials
2.1. shGCLUFL DNA construct generation
A DNA construct was designed to harbor a LoxP-ﬂanked small
hairpin RNA (shRNA) precursor against the catalytic subunit of gluta-
mate-cysteine ligase (GCL) (hereafter shGCL). Before recombination
(unswitched ﬂox or UFL), the shGCL sequence (5′-GAAGGAGGCTACT
TCTATA-3′) [18] was separated from the Pol-III promoter (H1) by the
LoxP and Lox2272 sequences in the appropriate positions and or-
ientations. Importantly, the shGCL has opposite strand orientation to
the H1 promoter. To clone the DNA fragment elements, we used
pIRES2-EGFP (Clontech), pSuper-neo/gfp (Oligoengine),
pCDNA3.1(+) (Invitrogen) and pEGFP-C1 (Addgene). The small se-
quence adaptors were designed and chemically synthesized (Thermo) to
introduce the LoxP and Lox2272 sites in the correct orientation and the
appropriate restriction enzymes sites. To construct shGCL [18], the
oligonucleotides were annealed and phosphorylated before ligation
with the corresponding linearized and dephosphorylated plasmids.
Elements from plasmids were excised by restriction enzyme digestion
and directly cloned into the linearized plasmids. The correct sequence
and orientations of the intermediary vectors were checked by restric-
tion enzyme assay and, for the ﬁnal clone containing shGCL (shGSLUFL),
by sequencing.
2.2. shGCLUFL/+ and CK2a-Cre/shGCLSLF mice generation
To generate mice harboring the shGCLUFL construct, the linearized
DNA was microinjected in the pre-fertilized pro-nucleus of a one-cell
state oocyte from the hybrid C57Bl/6J-CBA lineage at the Animal
Service of the University of Salamanca following standard protocols. A
founder, identiﬁed to harbor a unique integration site for shGCLUFL at
the fourth (N4) generation, was successively backcrossed with C57Bl/
6J until the congenic status (tenth generation) was achieved. Mice ex-
pressing Cre recombinase driven by the neuronal-speciﬁc promoter of
mouse calcium-calmodulin kinase 2a (CK2a-Cre) were purchased from
The Jackson Laboratories in a congenic C57BL/6 background.
According to The Jackson Laboratories datasheet, Cre recombinase
expression in this mouse is postnatal (from day 14–21 onwards) and
conﬁned mainly to the forebrain and hippocampus [19]. CK2a-Cre mice
were backcrossed for two generations in a C57BL/6J background to
obtain transgene homozygosis. To generate CK2a-Cre/shGCLSFL mice,
heterozygous shGCLUFL/+ mice were bred with homozygous (CK2a-
Cre/CK2a-Cre) mice. The eﬃcacy of the Cre-mediated recombination in
the CK2a-Cre/shGCLSFL mice, but not in the CK2a-Cre/+, was tested in
the hippocampus by PCR.
2.3. Tissue extraction
Male mice (9 months-old) were euthanized with CO2 and tissues
were extracted within the following 5min. Mice were decapitated, and
their brains were extracted and dissected. We collected the cerebellum,
striatum, hippocampus and pre-frontal cortex. For DNA extraction, a
small aliquot of tissue (tails or hippocampus) was placed in ice and
frozen until further processing. DNA was extracted from tails, pelleted
cells or tissue samples using the phenol-chloroform-isoamilic acid
method followed by isopropanol precipitation. DNA concentrations
were measured using NanoDrop 2000 (Thermo).
2.4. Genotyping
Genotyping was performed by PCR. To genotype the shGCLUFL
transgene, we used the following forward and reverse oligonucleotides
5′-AAGTCGTGCTGCTTCATGTG-3′ and 5′-ACGTAAACGGCCACAAG
TTC-3′, which generated a 200 bp band from the fragment placed
within the LoxP and Lox2272 sites of shGCLUFL. An internal control was
used to detect false negatives using the endogenous α-synuclein gene,
the forward and reverse oligonucleotides of which were, respectively,
5′-ATCTGGTCCTTCTTGACAAAGC-3′ and 5′-AGAAGACCAAAGAGCAA
GTGACA-3′, which generated a 150 bp band. To genotype the CK2a-Cre
transgene, a 270 bp region of Cre recombinase was ampliﬁed by PCR.
Forward and reverse oligonucleotides used were, respectively, 5′-GCA
TTTCTGGGGATTGCTTA-3′ and 5′-CCCGGCAAAACAGGTAGTTA-3′,
using the same α-synuclein oligonucleotides as above as the internal
control. PCR conditions were: 3 min at 94 °C, 35 cycles of 1) 1min at
94 °C, 2) 1min at 58 °C, 3) 1min at 72 °C and a ﬁnal step 10min at
72 °C. To detect the non-recombined state of the construct, we used the
following forward and reverse oligonucleotides, respectively, 5′-CATC
GAGCTGAAGGGCATC-3′ and 5′-CGGTGGGAGGTCTATATAAGCA-3′,
which ampliﬁed a 900 bp band. The recombined state was detected
using the forward and reverse oligonucleotides, respectively, 5′-GGTC
AGGGTGGTCACGAG-3′ and 5′-CGGTGGGAGGTCTATATAAGCA-3′, and
which ampliﬁed a 300 bp band. PCR conditions for both PCRs were:
3 min at 94 °C, 35 cycles of 1) 1min at 94 °C, 2) 1min at 55 °C, 3) 1min
at 72 °C and a ﬁnal step 10min at 72 °C.
2.5. Southern blotting
Genomic DNA from the tail (5–10 µg) was digested with HindIII, the
fragments were separated by agarose gel electrophoresis and trans-
ferred to a nylon membrane (Immobilon™ NY+, Millipore). After UV
crosslinking (Hoefer), the membrane was pre-hybridized with dena-
tured ssDNA and hybridized with the radiolabelled oligonucleotide
probe within the LoxP and Lox2272 sites of shGCLUFL. The radioactive
bands were visualized using a Phosphorimager screen (Fujiﬁlm) and the
images taken using a Bio-Rad Personal Molecular Imager.
2.6. Mouse embryonic ﬁbroblasts (MEFs) immortalization
Fibroblasts were prepared from fetal shGCLUFL/+ mice (E13.5).
Embryos were processed individually, and the liver and brain tissue
were disregarded. The carcass was mechanically disaggregated in
0.25 g/ml of trypsin/1mM EDTA and seeded in a 60 cm2 cell culture
dish containing DMEM (Life Technologies) supplemented with 10% (v/
v) fetal bovine serum (Linus) and 25mM D-glucose. Conﬂuent cells
were split 1:3 during 2 weeks, until the immortalization crisis occurred,
which lasted for a further 2 weeks. During this period, fresh medium
was replaced every 3 days. One week after the immortalization crisis,
single cell colonies were spotted, picked and grew. MEFs were frozen in
a mixture of FBS and DMSO (9:1). For experiments involving MEFs,
dishes and plates were previously coated with poly-D-lysine (15 μg/ml).
Cells were incubated at 37 °C in a humidiﬁed 5% CO2-containing at-
mosphere.
2.7. MEF transfections and treatments
Transfections of MEFs with plasmid vectors were performed using
Lipofectamine2000™ (Invitrogen), following the manufacturer’ in-
structions. After 6 h, fresh medium was added containing either 1 µM 4-
OH-Tamoxifen (TM) (Sigma) or vehicle (ethanol).
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2.8. Western blotting
Cells were lysed in RIPA buﬀer (2% SDS, 2mM EDTA, 2mM EGTA
and 50mM Trizma base, pH 7.5), supplemented with phosphatase in-
hibitors (100 μM phenylmethylsulfonyl ﬂuoride, 50 μg/ml antipapain,
50 μg/ml pepstatin, 50 μg/ml amastatin, 50 μg/ml leupeptin, 50 μg/ml
bestatin, 1 mM o-vanadate, 50mM NaF, and 50 μg/ml soybean trypsin
inhibitor) and boiled for 5min. Extracts were centrifuged at 13,000×g
for 5min at 4 °C, and aliquots of lysates (50 μg protein) were subjected
to sodium docedyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) on 8% acrylamide gel (MiniProtean®, Bio-Rad) including Dual
Colors™ (BioRad) as prestained protein ladder. The resolved proteins
were transferred electrophoretically to nitrocellulose membranes
(Hybond-ECL, Amersham Bioscience Europe GmbH). Membranes were
blocked with 5% (w/v) low-fat milk in 20mM Tris, 500mM NaCl, and
0.1% (w/v) Tween 20, pH 7.5, for 1 h. After blocking, membranes were
immunoblotted with 1:2000 rabbit anti-GCL (catalytic subunit)
(Abcam), 1:500 anti-GAPDH (6C5; Ambion) and 1:1000 anti-Map2 (AP-
20; Sigma-Aldrich) antibodies, overnight at 4 °C. After incubation with
horseradish peroxidase-conjugated goat anti-rabbit IgG (1:10,000 di-
lution, Pierce, Thermo Fischer Scientiﬁc) and/or goat anti-mouse IgG
(1:10,000 dilution, BioRad), membranes were immediately incubated
with the enhanced chemiluminescence kit SuperSignal West Dura
(Pierce, Thermo Scientiﬁc, Illinois, USA) for 5min, before exposure to
Kodak XAR-5 ﬁlm for 1–5min, and the autoradiograms were scanned.
2.9. Glutathione concentration determination in MEFs
Oxidized (GSSG) and total glutathione (GSx; GSx=GSH+2GSSG)
was measured in MEFs. For tissue samples, only total glutathione was
assessed. For MEFs, 1 ml of 5% (w/v) 5-sulfosalicylic acid (SSA) per 106
cells was added. An equal volume of NaOH 0.1M was added to the
same amount of cells for protein quantiﬁcation. In tissue samples, 20 µl
of 5% (w/v) of SSA was added per mg of tissue, and was diluted 1:5 for
subsequent glutathione measurement. In all cases, samples were pel-
leted and transferred to a fresh tube. For oxidized glutathione (GSSG)
determination, 60 µl of sample or GSSG standard were incubated with
3.43 µl of 2-vinylpiridine and 2.75 µl of triethanolamine for 1 h at 4 °C.
This derivatization reaction protects the sulfhydryl group forming a
tioether, which does not react in the determination assay. Thus, only
GSSG is measured in these samples. Reduced glutathione concentration
(GSH) was calculated from the formula GSx=GSH+2GSSG, according
to [20]. The assay uses NADPH(H+) and glutathione reductase (GSR) to
reduce back the oxidized glutathione upon formation, a reaction that is
coupled to the formation of TNB (λmax=405 nm) from GSH and DTNB.
In view that this is, therefore, a cycling reaction, the slope is registered
over a 10-min (20 iterations) period at 405 nm. The rates of TNB for-
mation in the samples were extrapolated to those obtained with GSSG
standards (Sigma). For GSx, GSSG standards were used in the range of
0–70 µM, whereas for GSSG, GSSG standards were used in the range
0–20 µM. The reaction composition consisted of 175 µl of 0.33mM
NADPH sodium salt prepared extemporarily in NaE buﬀer (143mM
sodium phosphate, 6.3mM EDTA, pH 7.5), 35 µl of H2O, 25 µl of 6 nM
DTNB (in NaE buﬀer), 10 µl of sample or standard and 50 µl of GSR (4
U/ml for GSx or 20 U/ml for GSSG determinations).
2.10. H2O2 determination
H2O2 assessment was performed in intact, seeded cells. 1.25×105
cells were incubated in 100 μM AmplexRed probe (Invitrogen) in Krebs-
Ringer phosphate buﬀer (145mM NaCl, 5.7mM Na2PO4, 4.86mM KCl,
0.54mM CaCl2, 1.22mM MgSO4 and 5.5 mM glucose), containing
horseradish peroxidase (0.5 U/ml). Luminescence was recorded for 2 h
at 30min intervals using a Varioskan Flash (Thermo Scientiﬁc,
Rockford, IL, USA) ﬂuorimeter (excitation: 538 nm, emission: 604 nm),
and the slopes were compared with those obtained with H2O2
(0–10 µM) for the calculations.
2.11. Thiols concentration determination
Cells seeded in 96-well plates at 2×105 cells/cm2 were washed
twice with PBS pH 7.4, incubated with 98 µl of SDS/EDTA buﬀer (SDS
2% (w/v) in 80mM phosphate buﬀer pH 8, containing 1mM EDTA),
and the absorbance was read at 412 nm. Then, 2 µl of freshly prepared
DTNB (10mM in 0.1mM phosphate buﬀer, pH 8) was added and ab-
sorbance was read again after 20min. Glutathione standards were
prepared in SDS/EDTA buﬀer. The absorbance at 0min was subtracted
from the absorbance at 20min, and thiols concentrations were inferred
from the glutathione standard curve.
2.12. Protein determination
Cells were lysed in 0.1M NaOH and used for the determination of
protein concentration by the BCA protein assay kit (Pierce), following
the manufacturer's instructions. Bovine serum albumin was used as
standard.
2.13. Protein carbonyl detection and proteomic analysis
These analyses were performed at the Proteomics Service of the
University of Lleida. Protein carbonyl groups were detected in SDS-
PAGE gels. Brain samples from 9 months-old mice were incubated in
20mM Tris-HCl, pH 7.5, plus a cocktail of protease inhibitors (Roche)
and disaggregated mechanically using an insulin syringe. For protein
carbonylation analyses, a volume containing 50 µg of protein was
treated with an equal volume of 15% SDS, 1% EDTA, 15% β-mercap-
toethanol in 0125M Tris-HCl pH 6.8. Samples were then derivatized
with Bodipy-FL hydrazide (Invitrogen, D-2371) as previously reported
[21]. Protein was then precipitated with 10% TCA for 30min at 25 °C.
Pellets were washed three times with 200 µl of ethanol: ethylacetate (1/
1) solution and air-dried. Samples were resuspended in Laemmli buﬀer
and analyzed in 10% PAGE-SDS electrophoresis gels. TCA-precipitated
protein samples were also used for 2D-gel electrophoresis analyses, as
described [22]. For this purpose, proteins were resuspended in 25 µl of
7M urea, 2M thiourea, 40mM Tris, 1% C7BzO, pH=10.4 Protein
Extraction Reagent Type 4, (Sigma, C3056) at 25 °C under continuous
shaking at 1400 rpm. Bodipy-derivatized proteins were separated in
two-dimensional gels and visualized by epiﬂuorescence using speciﬁc
channel settings for Bodipy-FL. Total protein staining was performed
with Flamingo Fluorescent gel stain (Bio-Rad). Images were captured
with a VersaDoc MP4000 Imager and analyzed with PDQuest software
(Bio-Rad). For each spot, a normalized value was obtained by estab-
lishing a ratio between Bodipy signal versus protein signal. Spots in 2D-
gels samples displaying a ratio greater than 1.5 with respect to the
matched control were selected for further identiﬁcation by peptide
mass ﬁngerprinting using an Autoﬂex-Speed MALDI ToF/ToF mass
spectrometer (Bruker Daltonics).
2.14. Mice perfusion and immunohistochemistry
Male mice (9 months-old) were anesthetized by intraperitoneal in-
jection of a mixture of xylazine hydrochloride (Rompun; Bayer) and
ketamine hydrochloride/chlorbutol (Imalgene; Merial) (1:4) at 1ml per
kg of body weight, and then perfused intraaortically with 0.9% NaCl
followed by 5ml/g body weight of paraformaldehyde (PFA, 4% (w/v))
in 0.1M phosphate buﬀer (PB) at pH 7.4. After perfusion, brains were
dissected out sagittally in two parts and post-ﬁxed using 4% PFA
overnight at 4 °C. Brain blocks were rinsed successively for 10min,
30min, and 2 h with 0.1 M PB solution and cryoprotected in 10%, 20%
and 30% (w/v) sucrose in PB solution sequentially, until they sank.
After cryoprotection, 30-μm-thick sagittal sections were obtained with a
freezing-sliding cryostate (Leica; CM1950 AgProtect). The sections
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were collected serially in a 12 well plate in 0.1 M PB and rinsed 3 times
for 10min in 0.1 M PB and used for subsequent immunohistochemistry.
The section-containing wells that were not used were kept in 0.05%
sodium azide (w/v) in 0.1M PB at 4 °C. For immunohistochemistry,
sections were incubated sequentially in (i) 5 mg/ml sodium borohy-
dride in PB for 30min (to remove aldehyde autoﬂuorescence); (ii) three
PB washes 10min each; (iii) 1:200 anti-CK2a (6G9; ENZO), 1:500 anti-
CK2a (bs-1647R; Bioss Inc), 1:250 anti-GCL (sc22755; Santa Cruz),
1:500 anti-GFAP (G6171; Sigma-Aldrich), 1:200 anti-GSH
(A001–50UG; Arbor Assays), 1:500 anti-IBA1 (019–19741; Wako), or
1:500 anti-MAP2 (AP-20; Sigma-Aldrich) in 0.02% Triton X-100
(Sigma-Aldrich) and 5% goat serum (Jackson Immuno-Research) in
0.1 M PB for 72 h at 4 °C; (iv) three PB washes 10min each; (v) ﬂuor-
ophore conjugated secondary antibodies, 1:500 Cy2 goat anti-mouse,
1:500 Cy2 goat anti-rabbit, 1:500 Cy3 goat anti-mouse, or 1:500 Cy3
goat anti-rabbit (Jackson Immuno-Research) in PB for 2 h at room
temperature; and (vi) 0.5 μg/ml DAPI in PB for 10min at room tem-
perature. After rinsing with PB, sections were mounted with
Fluoromount (Sigma-Aldrich) aqueous mounting médium [23].
2.15. Nissl staining
Sections obtained as previously described were mounted in slides
and left to dry overnight at room temperature. Slides were immersed in
a Coplin jar in absolute ethanol and chlorophorm mix (1:1) overnight,
and sequentially immersed for 5min each in a battery of ethanol so-
lutions at decreasing concentrations, starting from xylol down to dis-
tilled water for rehydration. Then, the slides were immersed again in
Nissl dye, consisting of 0.1% (w/v) cresyl violet and 0.3% (v/v) glacial
acetic in water, for 10min at room temperature. Afterwards, sides were
washed under tap water, distilled water and, ﬁnally, with 96% ethanol,
and mounted in Entellan solution (Sigma).
2.16. Imaging and quantiﬁcation
Sections were examined with epiﬂuorescence and appropriate ﬁlter
sets using an inverted microscope (Nikon; Eclipse Ti-E) equipped with a
pre-centered ﬁber illuminator (Nikon; Intensilight C-HGFI) and B/W
CCD digital camera (Hamamatsu; ORCA-ER). Confocal images were
acquired using a spectral laser confocal microscope (TCS-SL; Leica
Microsystems) and an inverted confocal microscope (TCS SP5; Leica
Microsystems). Large ﬁelds of view were acquired with an HCX Plan
Apo CS2 40× (N.A. 1.30) with a pixel size of ~300 nm at a scan speed
of 400 Hz using three line averages. High-resolution images were ac-
quired using an HCX Plan Apo CS2 63× oil objective (N.A. 1.40) with a
pixel size of 100 nm and a z-step size of 290 nm at a scan speed of
400 Hz using three lines averages. Immunohistochemical digital images
were used to analyze protein staining in the three most medial sagittal
sections per animal from four diﬀerent animals per condition (n=4).
Images were exported into the NIH image-processing package ImageJ
(version 1.47) in tiﬀ format for processing. Before image analysis, a
maximum-intensity projection over z-series projections spanning
15–16 µm was performed. Images were converted to gray scale 8-bit
images and brightness/contrast was adjusted using the ImageJ “auto”
function. Staining was automatically delineated using the “auto setting
threshold” (default method) and “dark background” functions of
ImageJ. Thresholded images were subsequently quantiﬁed as percent
area (area fraction) using the “analyze-measure” function, which re-
presents the percentage of pixels in the image that have been high-
lighted (% area) [23]. We also quantiﬁed the number of CK2a-positive
cells (neurons) that were GCL- or GSH-positive in images of the three
most medial sagittal sections per animal from four diﬀerent animals per
condition (n=4). In each studied area (CA1, CA3 and DG), we selected
a speciﬁc area and were quantiﬁed in a blinded fashion using NIS
Elements AR 3.22 (Nikon Inc.; Tokyo, Japan) the cells that were CK2a-
positive and GCL- or GSH-positive (colocalization), and the data were
expressed as number of GCL+/CK2a+ or GSH+/CK2a+ cells per µm2.
2.17. Behavioral tests
2.17.1. Motor balance and coordination
These were analyzed using the Rotarod test (Rotarod apparatus,
Model 47600, Ugo Basile) every eight weeks in six male mice per
condition. Male mice were previously trained during three consecutive
days, two weeks before the ﬁrst test. Each test was performed in three
consecutive days at the same time of the day. The rotarod conditions
were 300 s of continuous acceleration from 4 to 40 rpm with a net 4-
rpm rise every 30 s, reaching the ﬁnal speed at 270 s. Data from tests in
which animals completed 3 turns without walking were disregarded.
2.17.2. Cognitive performance
Animals were left to acclimatize in the room for not less than 15min
at the same time slot of the day (2–8 pm). Tracking was carried out once
at a time and carefully cleaning the apparatus with 70% ethanol be-
tween trials to remove any odor cues. For the Open Field and Hole
Board tests, an ANY-box® core was used, which contained a light gray
base and an adjustable perpendicular stick holding a camera and an
infrared photo-beam array to track the animal movement and to detect
rearing behavior, respectively. Mouse movements were tracked with
the ANY-maze® software and the AMi-maze® interface to register all
parameters described subsequently. For the Open Field test, a 40 cm ×
40 cm × 35 cm (w, d, h) black infrared transparent Perspex insert was
used, and the arena was divided in three zones, namely border (8 cm
wide), center (16% of total arena) and intermediate (the remaining
area). The test lasted for 30min, the distance travelled and the time
spent in each zone were measured. The head dipping (nose pokes) on a
Hole Board was used as an indicator of exploratory tendencies and lo-
comotor activity-independent anxiety. To do this, a 40 cm × 40 cm (w,
d) raised base with 16 holes (3 cm diameter each), arranged in a 4×4
grid raised 10 cm above the ﬂoor, ﬁtted snugly inside, and a black
Perspex insert infrared transparent (40 cm × 40 cm × 35 cm, w, d, h,
respectively) was used. The test lasted for 5min, and the total number
of nose pokes was measured.
2.17.3. Spatial learning and memory
This was performed using the Radial Arm Maze test without any
food restriction/food reward. A cued version was used instead taking
advantage of the exploratory nature of mice that drives it to explore
unvisited arms. The equipment consisted of eight equidistantly spaced
arms radially placed from a small circular central platform (Stoelting).
Each arm is 5 cm × 35 cm × 9 cm (w, l, h, respectively), geometric
ﬁgures were placed in the arms as spatial cues, and the equipment was
sub-divided in the following zones (in this order, anticlockwise), 1)
empty arm, with no ﬁgures attached to the wall (start arm); 2) diamond
arm, with 13 diamonds (6 per wall, plus one more at the end of the
arm); 3) circle arm, with 11 circles (5 per wall, plus one more at the end
of the arm); 4) square arm, with 11 squares (5 per wall, plus one more
at the end of the arm); 5) cross arm, with 9 crosses (4 per wall, plus one
more at the end of the arm); 6) triangle arm, with 13 triangles (6 per
wall plus, plus one more at the end of the arm); 7) star arm, with 11
jagged circles (5 per wall, plus one more at the end of the arm); and 8)
rectangle arm, with 11 rectangles (5 per wall, plus one more at the end
of the arm). A “non-return” sequence was programmed in the software
in order to count the number of non-return explorations (all arms vis-
ited without repeating a previously visited arm). The test duration was
15min, and the number of “non-return” and broken sequences (errors)
were measured.
2.17.4. Short-time memory
This was determined using the Novel Object Recognition test
(Stoelting) in a 40 cm × 40 cm × 35 cm (w, d, h) core with black in-
frared transparent Perspex insert. Mice were accustomed to this
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environment for 10min during two consecutive days, and the test was
performed on the third day. Mice were left to explore two identical
equidistant cubes for 3min (the acquisition phase), and returned for
15min into its cage. One cube was substituted for a similar size sphere
and mice were left to explore the objects for other 3min (the retention
phase). The ability to recognize the sphere as a novel object was de-
termined as the ratio time spent watching the sphere/time spent
watching the cube.
2.18. Experimental design and statistical analysis
Immunocytochemical quantiﬁcations were performed in brain
samples from four male mice (n= 4). The protein carbonyls assessment
was performed in the brain samples from three male mice (n=3). For
the behavioral experiments, six male mice (n= 6) were used per con-
dition. The values were expressed as mean ± standard error of the
mean (SEM). The statistical comparisons between two groups of values
were performed using the Student's t-test. In all cases, p < 0.05 values
were considered signiﬁcant. Statistics were performed using the IBM
SPSS Statistics software.
2.19. Animal procedures
All procedures performed with mice were approved by the Bioethics
Committee of the University of Salamanca in accordance with the
Spanish guidelines and regulations (law 6/2013).
3. Results
3.1. Neuron-speciﬁc GCL knockdown causes mild GSH deﬁciency in mice in
vivo
To induce cell-speciﬁc knockdown of GCL, we designed a DNA
plasmid harboring a previously validated [18] small hairpin RNA
(shRNA) sequence targeted against GCL (shGCL). The shGCL sequence
was preceded by a LoxP/Lox2272-ﬂanked RNA polymerase III (pol III)
H1 promoter inserted in the inverse orientation (unswitched ﬂox shGCL
or shGCLUFL (Fig. 1A). This construct was designed to obtain switching
of the LoxP/Lox2272-ﬂanked region upon Cre recombinase-mediated
activity to arrange the H1 promoter in the sense orientation (switched
ﬂox shGCL or shGCLSFL), thus amenable to trigger polymerase III-
mediated shGCL transcription (Fig. 1A). During the construction of this
DNA, an intermediary plasmid (pPX) harboring two unique restriction
sites (BglII and HindIII) was generated, which is therefore ready for the
insertion of any shRNA sequence (Fig. 1B; left panel). Insertion of the
shGCL cDNA fragment into pPX yielded a plasmid (pPXI or shGCLUFL;
Fig. 1B, right panel) that was used to generate transgenic mice under a
C57Bl/6J-CBA hybrid lineage. A founder identiﬁed to harbor a unique
integration site for shGCLUFL at the fourth (N4) generation (Fig. 1C),
was successively backcrossed with C57Bl/6J until the congenic status
(tenth generation) was achieved. To knockdown GCL in vivo, we next
bred heterozygous shGCLUFL/+ mice with homozygous mice expres-
sing Cre recombinase driven by the neuron-speciﬁc calcium-calmodulin
kinase-2a (CK2a) promoter (CK2a-Cre/CK2a-Cre). Eﬀective in vivo Cre-
mediated recombination in the CK2a-Cre/shGCLSFL, but not in the
CK2a-Cre/+ progeny was demonstrated by PCR in the hippocampus
(Fig. 1D), i.e. the brain area where CK2a promoter is most active [19].
Furthermore, according to the immunoﬂuorescence quantiﬁcations in
the hippocampal CA1, CA3 and dentate gyrus (DG) regions, GCL and
GSH abundances were moderately, albeit signiﬁcantly reduced in the
three analyzed regions, being the most prominent decrease observed in
the CA1 layer (Fig. 1E; Supplementary Fig. S1A–E).
3.2. GCL knockdown in neurons in vivo causes redox stress and oxidation of
important proteins in the hippocampus
To test if GCL knockdown triggered redox stress, we ﬁrst whether
the decreased GSH and thiols were associated with increased ROS in
shGCLSFL mouse embryonic ﬁbroblasts (MEFs). Induction of Cre-medi-
ated recombination in shGCLUFLMEFs eﬃciently decreased GCL protein
abundance, as judged by western blotting, along with decreased total
thiols and glutathione (total and reduced forms) (Supplementary Figs.
S2A-C); in contrast, oxidized glutathione (GSSG) and ROS (H2O2) were
increased (Supplementary Figs. S2C,D). These results, even not being a
direct in vivo evidence, show that GCL knockdown causes redox stress in
shGCLSFL cells. Next, we sought to investigate if GCL knockdown trig-
gered redox stress in vivo. To do so, we assessed the abundance of
protein carbonyls, i.e. a hallmark of ROS-mediated protein oxidation
[24], in diﬀerent brain areas. As shown in Fig. 2A and Supplementary
Fig. S2E, protein oxidation was signiﬁcantly increased in the hippo-
campus of CK2a-Cre/shGCLSFL mice when compared with controls
(CK2a-Cre/+). However, this eﬀect was not observed in the other brain
regions analyzed, i.e. cerebellum, striatum and prefrontal cortex
(Fig. 2A and Supplementary Fig. S2E). Given that the hippocampus was
the brain region in which protein carbonylation was most aﬀected, we
next performed two-dimensional gel electrophoresis of these samples.
As shown in Fig. 2B, we observed thirteen proteins that were oxidized
by ~ 2–3-fold (see also Supplementary Fig. S2F). After puriﬁcation and
mass spectrometry analysis of these samples, we identiﬁed oxidized
proteins involved in processes such as lysosomal traﬃcking (VATA,
VATB), axonal growth and guidance (DPYL2), glycolysis (ENOG, ENOA,
GAPDH and PGAM1), mitochondrial energy metabolism (PDHE1 and
MDH1), energy homeostasis (KCRB) and protein translation (EF1A1)
(Fig. 2B). Thus, knockdown of GCL leading to mild decrease in GSH in
the hippocampus causes the oxidation of speciﬁc proteins important for
neuronal functions.
3.3. Neuron-speciﬁc GCL knockdown in vivo causes dendrite disruption in
the CA1 region of the hippocampus
In view that the hippocampus of the CK2a-Cre/shGCLSFL mice was
the brain area in which protein oxidation was strongest we further
analyzed this area morphologically, immunohistochemically and bio-
chemically. We found no evidence of the typical morphological changes
associated with neuronal loss, including the DG, CA1 and CA3 width,
the cortex layers length, or cell density in the striatum (Supplementary
Figs. S3A and S3B). However, a highly signiﬁcant dendrite disruption
was observed in the CA1 region of the hippocampus. However, ac-
cording to MAP2 staining, MAP2 protein abundance (Fig. 3A-C), and
TUJ1 staining (Fig. 3D and E), our data are compatible with morpho-
logical changes in neurons compatible with dendrite disruption in the
CA1 region of the hippocampus. Interestingly, dendrite organization in
the CA3 or DG regions was unaﬀected (Fig. 3A, B, D and D). Since
dendrite disruption might cause glial inﬂammation, we examined re-
active astrocytes and microglia in these hippocampal regions. As shown
in Fig. 3C and D, an increase in the GFAP and IBA1 staining -markers of
astrocyte and microglial inﬂammation, respectively- was observed in
the CA1, but not in the CA3 or DG regions of the hippocampus. Thus,
mild GSH deﬁciency in the CK2a-Cre/shGCLSFL hippocampus causes
neuronal dendrite disruption, speciﬁcally in the CA1 region, an eﬀect
that is anatomically linked with glial inﬂammation.
3.4. Knockdown of GCL in vivo triggers behavioral signs of cognitive decline
To assess whether oxidative stress in the hippocampus of the CK2a-
Cre/shGCLSFL mice was suﬃcient to trigger signs of neurological da-
mage, we performed a set of behavioral tests, blinded to the operator
and digitally-registered. The body weight was unaltered at least up to
40 weeks of age in the CK2a-Cre/shGCLSFL mice when compared with
S. Fernandez-Fernandez et al. Redox Biology 19 (2018) 52–61
56
their controls (CK2a-Cre/+) (Fig. 4A). However, we found an age-de-
pendent decline in the performance of the rotarod test in the CK2a-Cre/
shGCLSFL mice (Fig. 4B), reﬂecting a progressive deterioration of motor
balance and coordination. Spatial memory, as revealed by the higher
number of broken sequences in the radial arm maze test, was sig-
niﬁcantly impaired (Fig. 4C) as it was the performance at the novel
object recognition test, indicating loss of short-term memory (Fig. 4D).
Notably, these eﬀects were absent in the shGCLUFL mice when com-
pared with wild type mice (Supplementary Figs. S4A-G), thus ruling out
any inﬂuence of the transgene insertion site on cognitive and motor
functions. Fear/anxiety, which is reﬂected both by the nose pokes in the
hole board test (Fig. 4E) and the distance travelled and time spent in the
central zone of the open ﬁeld test (Fig. 4F and G), were unaﬀected.
Altogether, these ﬁndings indicate that a moderate decrease in GSH in
the CK2a-Cre/shGCLSFL mice causes dendrite disruption in the CA1
layer of the hippocampus along with cognitive and motor dysfunctions.
4. Discussion
Here we describe a transgenic mouse model that develops a mod-
erate deﬁciency of GSH in the neurons of the adult brain in vivo. Our
strategy to knockdown the catalytic subunit of the ﬁrst rate-limiting
enzyme of GSH biosynthesis, GCL, certainly diﬀers with previous ap-
proaches aimed to extinguish GSH [25]. Thus, a GCL catalytic subunit
ubiquitous knockout mouse model was ﬁrst reported [26,27], but it is
not viable beyond embryonic day 8th [26]. Recently, a neuron-speciﬁc
GCL knockout mouse model [28] was generated with the aim to era-
dicate, rather than attenuate, GSH abundance in neurons. Whereas the
knockout strategy is appropriate to demonstrate fundamental roles of
GSH in neurons [28], it does not seem to adequately resemble the
moderate brain GSH deﬁciencies that take place during aging and
neurodegenerative diseases [13]. Although this was also attempted in
dopaminergic neurons by the full-length GCL cDNA antisense approach
[29], it yielded a weak phenotype likely due to its promoter depen-
dence to activation by doxycycline, a compound with poor penetrance
across the blood brain barrier [30]. Accordingly, the mouse model of
neuron-speciﬁc GSH attenuation that we herein report is the ﬁrst to
resemble the moderate brain GSH deﬁciency that is compatible with
pathophysiological relevant situations.
The brain is particularly vulnerable to excess ROS [2,3,31], a fact
that is likely due, amongst other possible factors, to the very low
abundance of GCL and, accordingly, GSH [32]. In the brain, both GSH-
synthesizing enzymes –GCL and GSH synthetase– are expressed in
neurons and astrocytes, although more robustly in astrocytes [33,34].
In fact, astrocytes actively synthesize GSH, which is cleaved to the ex-
tracellular space and shuttled in the form of GSH precursors into neu-
rons [33,35]. Thus, although astrocytes protect neurons from oxidative
damage by supplying GSH precursors, neurons have to build up GSH by
Fig. 1. Neuron-speciﬁc GCL knock down causes mild GSH deﬁciency in mice in vivo. (A) Schematic representation of the DNA construct used to generate the
unswitched (shGCLUFL) transgenic mouse (upper panel). The small hairpin RNA sequence against the catalytic subunit of glutamate cysteine ligase (shGCL) was
preceded by a LoxP/Lox2272-ﬂanked H1 promoter and inserted in the inverse orientation. Upon Cre recombinase-mediated activity, the H1 promoter is rearranged
in the sense (switched) orientation (shGCLSFL) (bottom panel). (B) Restriction analysis of the pPX plasmid that harbors two unique restriction sites (BglII and HindIII)
(left panel). Insertion of the shGCL cDNA fragment into pPX yielded the shGCLUFL plasmid (pPXI; right panel). (C) Southern blot of DNA isolated from the hippo-
campus of transgenic, shGCLUFL/+, adult mouse at the fourth generation (N4) showing the unique integration site and the excised transgene. (D) The N4 generation
shGCLUFL/+ mice was backcrossed with C57Bl/6J until congenic status, and then bred with homozygous mice expressing Cre recombinase governed by the neuron-
speciﬁc calcium-calmodulin kinase 2-a promoter (CK2a-Cre/ CK2a-Cre). The image shows the PCR analysis of the DNA isolated from the hippocampus of the adult
CK2a-Cre/shGCLSFL and CK2a-Cre/+ mice. (E) Quantiﬁcation of the GCL and GSH staining in the hippocampal CA1 and CA3 layers and the dentate gyrus (GD) of the
9 months-old CK2a-Cre/shGCLSFL male mice. Data are mean ± SEM values (n= 4). *p < 0.05 (Student's t-test).
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the de novo synthesis pathway [18,35]. Hence, disruption of the GSH-
synthesizing enzyme GCL in neurons is appropriate for aﬀecting their
GSH abundance even in the presence of neighboring astrocytes [18].
Since the CK2a promoter is most active in the hippocampus [19], we
focused in this brain area to analyze GCL and GSH abundances in the
neurons. Consistently with this, we found that GCL and GSH levels
moderately decreased throughout the hippocampus of the CK2a-Cre/
shGCLSFL mice. Furthermore, protein carbonyls, which indicate protein
oxidation during GSH deﬁciency [36], were speciﬁcally high in the
hippocampus, without signiﬁcant aﬀection in the cortex, striatum or
cerebellum, i.e. brain regions with lesser CK2a promoter activity [19].
Protein glutathionylation, which is another type of protein post-
translational modiﬁcation that is consequence of GSH depletion, has
been suggested to promote loss of cell survival [37]. However, the
moderate GSH deﬁciency that we observed in the neurons of the hip-
pocampus did not cause brain morphological alterations compatible
with cell death. This contrasts with the abrupt neuronal death gener-
ated by GSH eradication in the GCL knockout model [28], further
supporting the notion that mild GSH deﬁciency, such as that herein
achieved, is a suitable approach to investigate functional roles of GSH
in living neurons.
To further investigate the potential consequences of mild GSH de-
ﬁciency for neuronal functions, we performed a mass spectrometry
analysis of the oxidized proteins found in the hippocampus. Protein
carbonylation is one of the markers of oxidative stress. Major pathways
leading to protein carbonylation are the consequence of iron imbalance
or lipid peroxidation. When available in the cell (mainly through the
labile iron pool), iron would promote protein carbonylation through the
well-known Fenton reaction. Since glutathione have been proposed as
the main iron(II) chelator [1,38], its deﬁciency could lead to increase
free iron and catalyze Fenton reaction. In this paper, the decreased GSH
synthesis caused by GCL knockdown, would favor protein oxidative
modiﬁcations observed by decreasing GSH pool. In fact, we identiﬁed
oxidized proteins known to regulate neuronal functions such as axonal
growth and guidance, lysosomal traﬃcking and energy metabolism.
Whilst future studies will be needed to deﬁne the repercussion that the
oxidation of each of these proteins has for neuronal function, our data
demonstrate that a moderate level of redox stress is suﬃcient to cause
posttranslational protein modiﬁcations. The immunohistochemical
characterization of the CK2a-Cre/shGCLSLF mice revealed neuronal
dendrites disruption in a deﬁned brain region, namely the CA1 layer of
the hippocampus. Interestingly, GCL and GSH deﬁciencies were ob-
served in the CA3 and DG regions, besides the CA1 layer, suggesting
higher vulnerability of the CA1 neuronal dendrites. The occurrence
glial inﬂammation limited to the CA1 layer strongly supports this no-
tion. Moreover, it should be noted that the decrease in GCL and GSH
staining was ~ 40% in neurons of the CA1 layer, in contrast with the
~ 30% loss observed in neurons of the CA3 and DG regions. Whether
there is a threshold eﬀect in dendrite disruption according to ﬁne
modulation of GSH levels is an interesting possibility worth pursuing. In
sustain of this concept, in a previously reported threshold study, it was
shown that the CA1 layer of the hippocampus is more vulnerable than
the paramedian cortex against a metabolic stress [39].
According to the behavioral tests performed in the CK2a-Cre/
shGCLSFL mice, both the spatial and short time memories were im-
paired. In principle, these ﬁndings are supported by previous studies
performed in the ubiquitous knockout model for the modulatory GCL
subunit [40,41]. However, whether the massive liver failure occurring
in that model explains the cognitive [40] and psychiatric [41] pheno-
types due to hepatic encephalopathy is unknown. In a more recent
study, neuron-speciﬁc loss of the catalytic GCL subunit was achieved
causing memory impairment [28]. Whilst this is an interesting ap-
proach to investigate fundamental roles of GSH, it abolishes GSH thus
triggering abrupt neurodegeneration [28], which likely accounted for
the cognitive impairment. In contrast, our GCL knockdown strategy
renders mice with spatial and short time memory loss despite GSH is
still present -although at a slight low level. Furthermore, neuronal
dendrite disruption was conﬁned to the CA1 layer of the hippocampus,
a region that is responsible for the control of the cognitive function
[17,42,43]. These studies further reinforce the link between mild loss of
hippocampal GSH and cognitive dysfunction in the CK2a-Cre/shGCLSFL
mouse. The slight motor impairment that occurred in the CK2a-Cre/
Fig. 2. GCL knock down in neurons in vivo causes oxidation of important proteins in the hippocampus. (A) Analysis of carbonylated proteins in diﬀerent brain areas.
Proteins obtained from diﬀerent brain areas of the 9 months-old CK2a-Cre/+ and CK2a-Cre/shGCLSFL male mice were solubilized and carbonyl groups were
derivatized with Bodipy-Hydrazide. Protein samples (10 μg) were separated in monodimensional polyacrylamide gel electrophoresis (PAGE). For total protein
detection, gels were stained with Flamingo ﬂuorescent stain. (B) Two dimensional PAGE (2D-PAGE) (pH range 3–10) of Bodipy-derivatized proteins and Flamingo
staining. Arrows indicate spots corresponding to the most carbonylated proteins. Representative images are shown. Cb, cerebellum; Str, striatum, Hip, hippocampus;
PCx, prefrontal cortex.
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shGCLSFL mice reﬂects the possible aﬀection of brain areas that control
motor coordination. However, the striatum and cerebellum –brain re-
gions controlling these tasks– showed no apparent signs of oxidative
damage. Further studies would thus be required to address the speciﬁc
link between motor unbalance and hippocampal redox stress in the
CK2a-Cre/shGCLSFL mice.
In conclusion, here we show that moderate down modulation of
neuronal glutathione leads to dendrite disruption in a concrete set of
hippocampal neurons that cause behavioral symptoms compatible with
cognitive impairment and loss of motor coordination in mice. These
data suggest that ﬁnely tuning down glutathione is a suitable strategy to
ascertaining novel functions of this cofactor for neuronal activity.
Fig. 3. Neuron-speciﬁc GCL knock down in vivo causes dendrite disruption in the CA1 region of the hippocampus. (A) Immunostaining for the dendritic marker MAP2
(scale bars, 50 µm) showing dendrite disruption in the CA1 layer, but not in the CA3 layer and dendate gyrus (DG) of the hippocampus of the 9 months-old CK2a-Cre/
shGCLSFL male mice when compared with the littermates controls (CK2a-Cre/+). Representative images are shown. (B) Quantiﬁcation of the MAP2 staining images.
Data are mean± SEM values (n=4). *p < 0.05 (Student's t-test). (C) Western blot against MAP2 in the hippocampus and cerebellum showing decreased MAP2
protein abundance in the hippocampus, but not in the cerebellum, of the 9 months-old CK2a-Cre/shGCLSFL male mice when compared with the littermates controls
(CK2a-Cre/+). A representative western blot is shown. (D) Immunostaining for the dendritic marker TUJ1 (scale bars, 50 µm) showing dendrite disruption in the
CA1 layer, but not in the CA3 layer and dendate gyrus (DG) of the hippocampus of the 9 months-old CK2a-Cre/shGCLSFL male mice when compared with the
littermates controls (CK2a-Cre/+). Representative images are shown. (E) Quantiﬁcation of the TUJ1 staining images. Data are mean ± SEM values (n=4).
*p < 0.05 (Student's t-test). (F) GFAP and IBA1 staining (scale bars, 50 µm), indicators of astrocyte and microgial inﬂammation, respectively, reveals inﬂammation
in the CA1, but not in the CA3 or DG regions of the hippocampus of the CK2a-Cre/shGCLSFL mice when compared with the littermates controls (CK2a-Cre/+).
Representative images are shown. (G) Quantiﬁcation of the GFAP and IBA1 staining images. Data are mean ± SEM values (n=4). *p < 0.05 (Student's t-test).
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